Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
Antigen-presentingcells
B cell
Cluster of differentiation
Dendritic cells
Human papillomavirus
Macrophage
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
15
03
2022
revised:
16
05
2022
accepted:
23
05
2022
pubmed:
1
6
2022
medline:
22
6
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
Viruses may transform infected cells into benign or malignant tumors, promoting cell growth and survival via various intracellular pathways. Some oncogenic DNA viruses, such as human papillomaviruses, can lead to squamous intraepithelial lesions and cervical cancer. Furthermore, the early HPV virus'soncoproteins have been attributed to cancer initiation and development and tumor-enhancing action. In addition to viral oncoproteins, antigen-presenting cells (APC) and the number of clusters of differentiation (CD) markers expressed on their surface play an essential role in disease progression or tumorigenesis inhibition. This article discussed the function of CD markers in the interaction between APCs and cancer cells, immune cells' function in the infection process, and finally infected cells' malignancy. We investigated targeting these markers as a novel insight to create a new therapeutic or diagnosis strategy to prevent cervical cancer progression.
Identifiants
pubmed: 35640377
pii: S1567-5769(22)00380-0
doi: 10.1016/j.intimp.2022.108896
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
108896Informations de copyright
Copyright © 2022. Published by Elsevier B.V.